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ABSTRACT
Background. Chronic fatigue syndrome (CFS) and depression share a number of common
symptoms and the majority of CFS patients meet lifetime criteria for depression. While cognitive
factors seem key to the maintenance of CFS and depression, little is known about how the cognitive
characteristics differ in the two conditions.
Methods. Fifty-three CFS patients were compared with 20 depressed patients and 38 healthy
controls on perceptions of their health, illness attributions, self-esteem, cognitive distortions of
general and somatic events, symptoms of distress and coping. A 6 month follow-up was also
conducted to determine the stability of these factors and to investigate whether CFS-related
cognitions predict ongoing disability and fatigue in this disorder.
Results. Between-group analyses confirmed that the depressed group was distinguished by low
self-esteem, the propensity to make cognitive distortions across all situations, and to attribute their
illness to psychological factors. In contrast, the CFS patients were characterized by low ratings of
their current health status, a strong illness identity, external attributions for their illness, and
distortions in thinking that were specific to somatic experiences. They were also more likely than
depressed patients to cope with their illness by limiting stress and activity levels. These CFS-related
cognitions and behaviours were associated with disability and fatigue 6 months later.
Conclusions. CFS and depression can be distinguished by unique cognitive styles characteristic of
each condition. The documented cognitive profile of the CFS patients provides support for the
current cognitive behavioural models of the illness.
INTRODUCTION
Chronic fatigue syndrome (CFS) is a disorder of
uncertain aetiology, characterized by de-
bilitating fatigue which has been present for at
least 6 months (Fukuda et al. 1994). The
idiopathic nature of CFS has led to an ongoing
debate as to the organic or functional aetiology
of this disorder. Those favouring an organic
cause have linked CFS to viral pathogens, muscle
abnormalities, and immunological and neuro-
logical changes. While a number of abnor-
malities have been documented in CFS groups,
" Address for correspondence: Dr Rona Moss-Morris, Health
Psychology Research Group, The Faculty of Medical and Health
Science, The University of Auckland, Private Bag 92 019, Auckland,
New Zealand.
no clear distinguishing organic agent has been
found (Evengard et al. 1999). The lack of a
defining pathophysiology has led others to
suggest that CFS is a somatic form of depression
(Manu et al. 1993).
The argument for CFS as a form of depression
is based on the significant overlap between these
two disorders. CFS shares a number of cardinal
symptoms with depressive disorders including
extreme fatigue, sleep disturbance, diminished
concentration, and problems with memory. In
fact, up to 85% of CFS patients report depressed
mood as a key symptom (Komaroff & Buchwald,
1991) and around two-thirds of patients meet
lifetime criteria for depression (Abbey, 1996).
Studies comparing CFS patients to patients with
a range of medical illnesses, including rheu-
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matoid arthritis, multiple sclerosis, neuro-
muscular disorders and myopathies have in-
variably reported significantly higher rates of
depression in CFS (Wessely & Powell, 1989;
Katon et al. 1991; Wood et al. 1991; Pepper et
al. 1993; Johnson et al. 1996).
Despite this overlap, there is evidence that
relevant differences may exist. Studies of the
neuroendocrine system have demonstrated sig-
nificantly different physiological abnormalities
in each of these disorders, although results have
not always been consistent (Schwartz et al.
1994; Cleare et al. 1995; Goldstein et al. 1995;
Fischler et al. 1996). In addition, unlike de-
pressed patients, CFS patients do not seem to
respond to antidepressant medication (Natelson
et al. 1996; Vercoulen et al. 1996).
A closer look at the psychological symp-
tomatology of these groups shows that CFS
patients consistently report lower mean scores
on depression inventories, although their scores
are still within the depressed range (Hickie et al.
1990; Johnson et al. 1996; Wessely & Powell,
1989). These differences are largely accounted
for by depressed patients scoring significantly
higher on the self-reproach or cognitive
symptoms including feelings of guilt, low self-
esteem, and suicidal ideation (Powell et al. 1990;
Johnson et al. 1996).
Amore detailed investigation of the cognitions
of the two groups may provide another avenue
to determine whether depression and CFS are
indeed distinct. Not only do cognitive symptoms
form part of the DSM-IVdiagnosis of depression
but cognitive theories of depression suggest that
specific thought processes define the disorder
(Beck, 1964). The characteristic cognitive profile
of depressed patients includes a negative self-
concept, and themes of loss, abandonment and
defeat (Beck, 1964). This negative self-schema is
thought to generate a series of distortions in
thinking such as selective abstraction – focusing
on the negative aspects of an experience,
catastrophising – expecting the worst outcome
to occur, personalization – seeing oneself as
responsible for negative events, and overgeneral-
izing – assuming the negative consequences of
one experience apply to another (Beck, 1964;
Beck et al. 1978). These distorted thought
processes and negative self-concept distinguish
depressed patients from patients with other
forms of psychopathology (Mathews &
MacLeod, 1994). Thus, if CFS is distinct from
depression, CFS patients should not report these
classic errors of thinking.
Our previous work has shown that CFS
patients appear to have a particularly negative
view of their illness and to be less likely to
attribute their illness to internal factors when
compared to patients with other chronic medical
conditions (Weinman et al. 1996). They also
tend to make catastrophic interpretations of the
consequences of their illness (Petrie et al. 1995).
Accordingly, we hypothesized that while de-
pressed patients ’ schema are dominated by
negative self-perceptions, CFS patients ’ per-
ceptions are dominated by their views of
themselves as seriously physically ill people.
Therefore, we anticipated that while depressed
patients would demonstrate negative distorted
thinking in a range of situations, CFS patients
would only demonstrate these distortions when
interpreting somatic information.
Comparing CFS and depressed patients’ cog-
nitions may not only help in differentiating the
phenomenology of the disorders. Recent models
of CFS suggest that patients’ cognitions play an
important role in maintaining this disorder
(Wessely et al. 1991; Surawy et al. 1995). In
particular, a precipitating event such as a virus is
seen to trigger a cycle of responses whereby
patients interpret ongoing symptoms as signs of
physical illness. This results in limiting activity
levels and the development of cognitions and
behavioural responses which are thought to
perpetuate the level of disability and fatigue
experienced by these patients. To date, the
nature of CFS patients’ cognitions have largely
been documented through clinical observation
and there is little empirical evidence to support
the unique nature of these belief structures.
Thus, the aims of the current study were as
follows. First, to compare the cognitions and
behavioural responses of CFS and depressed
patients to determine whether these disorders
have unique cognitive profiles. In particular, we
hypothesized that CFS patients’ negative cog-
nitions would be specific to health and illness,
that they would have a tendency to view their
illness as organic, and to limit their activity
levels in order to cope with their illness.
Secondly, to investigate whether this cognitive
profile remains stable over time and thirdly to
determine whether the CFS-related cognitions
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and behavioural responses predict ongoing
disability and fatigue in this disorder.
METHOD
Participants
Because of the phenomenological overlap be-
tween depression and CFS, an important com-
ponent of this study was ensuring the ap-
propriate allocation to groups. Standardized
diagnostic interviews were used in conjunction
with self-report measures to confirm patient
diagnoses. The CFS group was also divided
into those with and those without a concurrent
diagnosis of depression, to avoid the possible
confounding of dual diagnoses.
CFS group
The CFS patients were recruited from a general
medical practice specializing in the treatment of
CFS. Patients aged between 18–65 who were
diagnosed by the general practitioner as having
CFS, and who provided informed consent to
participate in the study were interviewed by one
of the investigators. Of the 65 patients who
provided informed consent, eight did not meet
criteria, and four dropped out of the study.
The diagnostic interview assessed whether
patients met current research criteria for CFS
(Fukuda et al. 1994) and whether they had a
concurrent diagnosis of depression. The inter-
viewer-administered computerized version of the
Composite International Diagnostic Interview
(CIDI-Auto) (Health, WHO, 1993) was used to
diagnose depression as it has been recommended
for use in CFS research (Fukuda et al. 1994).
Table 1. Characteristics of group participants
CFS CFS-depressed Depressed Healthy controls
(Nfl 39) (Nfl 14) (Nfl 20) (Nfl 38)
Gender,% Women (N) 82 (32) 85–7 (12) 65 (13) 74 (28)
v#fl 2–97, Pfl 0–40
Age, mean (s.d.) 43–3 (12–7) 47 (12–07) 38–8 (12–5) 44–9 (10–8)
Ffl 1–64; dffl 3, 107; Pfl 0–18
Tertiary qualified,% (N) 51 (20) 55 (11) 43 (6) 45 (17)
v#fl 4–1; Pfl 0–90
BDI scores, mean (s.d.) 11–68 (5–45) 14–12 (6–02) 22–47 (6–7) 4–00 (2–47)
Ffl 61–74; dffl 3, 107; P! 0–001
Length of illness, mean (s.d.) 8–9 (8–7) 7–8 (10–1) 14–1 (14–1)
Ffl 2–11; dffl 2, 70; Pfl 0–13
Unemployed*,% (N) 59 (23) 57 (8) 30 (6)
v#fl 4–7, Pfl 0–09
* Unemployment due to illness.
The CIDI-Auto has demonstrated procedural
validity against expert clinical diagnoses (Peters
& Andrews, 1993) and the items have good
reliability (Wittchen, 1994).
Fourteen (26%) of the 53 subjects had a
concurrent DSM-III-R diagnosis of major de-
pression or dysthymia, similar to a number of
other studies which have identified concurrent
depression in CFS (Katon et al. 1991; Bom-
bardier & Buchwald, 1995). In this study the
estimate of depression may have been con-
servative, as the CIDI excludes somatic symp-
toms from diagnostic criteria if they have been
attributed to physical illness by a medical
practitioner. As the role of somatic symptoms in
diagnosing depression in CFS is a controversial
issue (Ray, 1991), the conservative estimate was
deemed preferable. The final sample consisted of
39 CFS patients without depression (CFS) and
14 CFS patients with a concurrent diagnosis of
depression (CFS-depressed). Fifty-one per cent
of this group belonged to a CFS support group.
The demographic details of the two CFS groups
together with the comparison groups are pre-
sented in Table 1. Analysis of variance
(ANOVA) and chi-square tests were used to
confirm that the groups were comparable with
regard to demographic features.
Depressed group
Inclusion criteria for the depressed group,
included a current primary DSM-III-R diagnosis
of major depression or dysthymia, a Beck
Depression Inventory (Beck, 1978) score & 10,
no evidence of psychosis, organicity, addiction,
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Table 2. Current and past diagnoses of
depression across illness groups
CFS CFS-depressed Depressed
(Nfl 39) (Nfl 14) (Nfl 20)
% (N) % (N) % (N)
Current diagnoses
No diagnosis 100 (53)
Major depression 85–7 (12) 90 (18)
Dysthymia 14–2 (2) 10 (2)
Past history
No history 42–1 (16) 14–3 (2) 10 (92)
Major depression 50 (19) 78–6 (11) 85 (17)
Dysthymia 7–9 (3) 7–1 (1) 5 (1)
or chronic physical illness. To be comparable
with the CFS group, the depressed patients
needed to be receiving out-patient rather than
in-patient treatment and to be between 18- and
65-years old. Patients were recruited through
private psychologists and community mental
health centres. Subjects who provided informed
consent were interviewed with the CIDI to
confirm that they met current criteria for a
depressive disorder. Three of 23 patients inter-
viewed did not meet inclusion criteria. The final
primary depressed group consisted of two
patients with dysthymia and 18 with major
depression.
The CIDI data from all three patient groups
are presented in Table 2. Most of the CFS-
depressed and primary depressed patients met
criteria for major depression with only two
patients in each group meeting criteria for
dysthymia. The majority of the patients had a
history of depressive disorders, including 68%
of the non-depressed CFS patients.
Table 1 shows that the mean BDI score for
the primary depressed group was in the mod-
erately depressed range (Kendall et al. 1987) and
was substantially higher than the scores for the
two CFS groups. The means for the CFS groups
both fell within the mildly depressed range,
although the score for the CFS-depressed group
was higher than that of the CFS group.
Control group
The healthy controls were recruited through the
university and the community on the basis that
theymatched the patient groups as far as possible
for the demographic features identified in Table
1. Exclusion criteria were a BDI score & 10, a
current or past history of depression or CFS,
and}or a current chronic illness. A score & 10
on the BDI is indicative of possible depressive
disorder (Beck et al. 1978). Eight of the 46
healthy volunteers scored " 10 on the BDI
resulting in a final sample of 38 healthy controls.
Measures
Two types of measures were included in this
study, those measuring cognitive behavioural
factors and those assessing the specific symptom
profiles and level of disability of the groups.
The Self-Esteem Scale (Rosenberg, 1995)
This was used to operationalize negative self-
schema. It is the most frequently used measure
of self-esteem and has good internal reliability,
test–retest reliability, and convergent and dis-
criminate validity (Blascovich & Tomaka, 1991).
High scores represent greater self-esteem.
Self-rated health
Self-rated health was used as a measure of illness
schema. It is a widely used single-item measure
of individuals’ perceptions of themselves as
healthy or sick people (Johnston et al. 1995).
The Short Form Health Survey version of the
scale (Ware & Sherbourne, 1992) was used in the
current study, where low scores represent more
healthy perceptions.
Illness Perception Questionnaire (IPQ,
Weinman et al. 1996)
Two subscales of the IPQ were used to measure
dimensions of patients’ illness beliefs. The illness
identity subscale measures the number of so-
matic symptoms patients associate with their
illness. The identity scale in this study consisted
of 20 symptoms, including the 12 core IPQ items
which are symptoms commonly experienced by
the general population and eight additional
symptoms commonly reported by depressed and
CFS patients (Moss-Morris et al. 1996). The
causal subscale measures patients’ beliefs about
the causes of their illness. For the purpose of this
study patients were presented with a list of 18
possible causes of their illness. Half of these
were psychological causes such as ‘recent stress-
ful events’ and ‘my mental attitude’ while the
other half were physical causes such as ‘a virus’,
‘immune dysfunction’ or ‘a neurochemical im-
balance’. Subjects were asked to assign a
percentage to each factor, so that the overall
assignment of causes equalled 100%. If they
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believed the factor was unrelated to their illness
they were asked to assign the factor 0. Two
scores were computed, one which measured the
percentage patients assigned to physical causes
and the other the percentage assigned to psycho-
logical causes.
Cognitive Errors Questionnaire-Revised
(CEQ-R, Moss-Morris & Petrie, 1997)
The CEQ-R was devised specifically to assess
cognitive distortions in this study. The CEQ-R
is divided into two subscales : the 12-item
General CEQ-R and the 9-item Somatic CEQ-
R. Each of the 21 items describes an everyday
situation involving either work, recreation, or
family experiences. The general items focus on
interpersonal experiences, while the somatic ones
include the experience of common symptoms,
such as fatigue, aches and pains, and muscle
weakness. These vignettes are followed by a
thought that a person in that situation may
have. For example, one of the general items
states ; ‘You hand in a report to your boss that
has taken you four hours to write. Your boss,
however, doesn’t say anything about it. You
think to yourself, ‘‘ (S)he must think I did a lousy
job ’’ ’. An example of a somatic item is ‘You
have been feeling very weak and tired of late, but
have continued to work. Although you got quite
a bit done today, you finished work early because
you were feeling particularly exhausted. You
think to yourself, ‘‘What a terrible day. It seems
like I can’t get anything done ’’ ’. The thoughts
are worded to represent the cognitive errors of
catastrophizing, overgeneralizing, personali-
zation, and selective abstraction (Beck et al.
1978). An in depth analysis of this questionnaire
which included the current samples showed that
the subscales have high internal consistency
across groups and good test–retest reliability
over 6 months (Moss-Morris & Petrie, 1997).
Coping
A three-item measure of limiting coping was
included in the questionnaire (Sharpe et al.
1992). Patients were asked the extent to which
they limited exercise, activity, and stress in order
to cope with their illness on a 4-point scale rated
from ‘I usually didn’t do this at all ‘to’ I usually
did this a lot ’. These items have been shown to
predict ongoing disability in patients with
chronic fatigue (Sharpe et al. 1992).
Symptoms of distress and fatigue
Two subscales of the Mental Health Inventory
(Viet & Ware, 1983) that discriminate between
the somatic and affective components of distress
were used to substantiate the symptom dif-
ferences between the four subject groups. The
MHI-5 (Ware et al. 1993) is a measure of the
affective dimensions of anxiety, depression, and
psychological well-being. It has demonstrated
high internal consistency (Ware et al. 1993), and
is a valid measure of psychiatric dysfunction
(Berwick et al. 1991). The Vitality Scale (Ware et
al. 1993) is a 4-item measure of energy and
fatigue. The vitality scale has a sound record of
empirical validity, item discriminant validity,
and scale reliability (Ware & Sherbourne, 1992).
Both of these subscales are scored so that high
scores indicate greater psychological well-being
and vitality.
Disability
The Sickness Impact Profile (SIP, Gilson et al.
1979) was used as a measure of sickness related
disability. The SIP has been found to be a
convincing measure of functional status in a
range of chronic illnesses (De Bruin et al. 1992).
The questionnaire’s validity, test–retest re-
liability and internal consistency are well es-
tablished (De Bruin et al. 1992). Because the
scale is very lengthy and the reliability and basic
construct validity appear to be unaffected by
administering only selected subscale categories
(Bergner et al. 1981), six subscales were includ-
ed in the current study. Five of these
subscales – social interaction, alertness behav-
iour, sleep and rest, home management, and
recreational pastimes – have been shown to
most clearly represent CFS-related disability
(Schweitzer et al. 1995). These scores were
summed and divided by five to produce a SIP
dysfunction score out of 100. We also included
the SIP work subscale as a separate variable as
it was only relevant to the percentage of people
who were working before their illness.
Procedure
Items determining the demographic features of
the groups and the self-report measures were
compiled into a single questionnaire. The IPQ
subscales, SIP, and limiting coping scale, which
are specific to illness, were included only in the
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patient questionnaires. All participants provided
informed consent before they were given a copy
of the questionnaire and a self-addressed return
envelope. The patient groups also completed a
diagnostic interview to determine their eligibility
for the study. All subjects were asked to complete
the questionnaire within a week and to post it
back to the investigators.
Six months after completing the initial ques-
tionnaire, participants in the patient groups
completed a shortened version of the ques-
tionnaire included the MHI-5, Vitality, SIP,
Self-Rated Health, CEQ-R and Illness Identity
scales. Two of the depressed patients could not
be contacted and one depressed patient and two
CFS patients did not return the questionnaire.
The overall response rate of the follow-up
questionnaire was 85% for the depressed group,
95% for the CFS group and 100% for the CFS-
depressed group.
RESULTS
Data analysis was performed on the SPSS
version 8.0 computer software program
(Norus) is, 1993). Results of the evaluation of the
assumptions of normality of sampling dis-
tributions, linearity, and homogeneity of vari-
ance were satisfactory for all of the variables
and there were no obvious outliers. A series of
Analysis of Variance (ANOVA) were used to
test the hypotheses regarding differences between
the groups. Due to the large number of planned
analyses, a Bonferonni adjusted alpha was used
in these equations; P! 0–0045 (0–05}11) at time
Table 3. Analysis of variance of the self-report measures at Time 1
CFS CFS-depressed Depressed Controls
Mean (s.d.) Mean (s.d.) Mean (s.d.) Mean (s.d.) df F
Vitality 26–54 (18–54) 20–71 (18–69) 26–50 (14–96) 68–69 (15–14) 3,107 55–46*
MHI-5 68–10 (15–60) 47–43 (3–75) 36–40 (15–57) 79–58 (10–26) 3,107 51–05*
SIP dysfunction 42–17 (13–79) 47–59 (14–14) 44–82 (13–82) 2,67 0–83
SIP work 58–48 (17–48) 59–69 (33–64) 52–29 (24–94) 2,54
Self-esteem 31–25 (4–73) 27–71 (5–67) 24–86 (5–76) 33–11 (4–12) 3,107 14–85*
Self-rated health 4–05 (0–79) 4–00 (0–96) 3–15 (1–14) 1–76 (0–68) 3,107 52–86*
General CEQ-R 21–69 (8–99) 26–03 (7–79) 35–15 (11–85) 21–47 (6–58) 3,107 10–66*
Somatic CEQ-R 21–79 (8–16) 21–36 (6–22) 23–24 (9–1) 14–83 (4–65) 3,107 12–97*
Somatic illness identity 17–59 (2–20) 18–21 (2–33) 13–40 (3–94) 2,70 17–82*
Psychological attributions 25–39 (24–99) 17–86 (21–81) 62–13 (23–42) 2,68 19–31*
Physical attributions 62–11 (28–62) 77–86 (21–81) 15–90 (16–12) 2,68 31–04*
Limiting coping 9–87 (1–80) 8–79 (2–61) 7–05 (2–48) 2,70 11–04*
* P! 0–0045.
 Significantly different from the control group.
 Significantly different from the depressed group.
 Significantly different from the CFS group.
one and P! 0–007 (0–05}7) at time two. To
ascertain whether covariates should be included
in these equations, correlations were computed
between age, gender, level of education, marital
status, length of illness, and the various de-
pendent variables (DVs). There were no sig-
nificant correlations, and as there were no
significant differences between the groups on
these factors, no covariates were included. Post-
hoc analyses were conducted with Tukey’s test.
Stepwise multiple regression was used to in-
vestigate the relationships between the cognitive
behavioural factors and ongoing disability and
fatigue in the CFS group.
Symptoms and disability across groups
A summary of the ANOVA results from time
one are presented in Table 3. The first stage of
the analyses involved clarifying the validity of
the four groups by comparing their scores on the
MHI-5 and Vitality scales. Vitality scores were
significantly different between groups. Post-hoc
tests suggested that this difference was due to the
higher scores for the control group when
compared to all three patient groups, who had
equivalent scores. MHI-5 scores also differed,
with post-hoc analyses suggesting a number of
significant contrasts between the four groups.
As with the Vitality scale, healthy controls
scored significantly higher on the MHI-5 than
all the patient groups. CFS non-depressed
patients also scored significantly higher than
both the depressed groups and CFS-depressed
patients scored higher than primary depressed
patients.
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The ANOVA of the SIP data showed there
were no differences in the level of sickness
related disability reported by all three groups.
Thus, in terms of presentation, CFS and de-
pressed patients appear to report equivalent
levels of energy loss and disability. Depressed
patients however report higher levels of negative
mood than do CFS patients.
Cognitive behavioural factors across groups
Self-esteem
Comparisons confirmed that the two depressed
groups had significantly lower self-esteem than
the CFS non-depressed and healthy control
groups. There were no significant differences
between the two depressed groups, or between
the CFS non-depressed and healthy control
groups.
Self-rated health
The ANOVA for self-rated health showed that
both CFS groups rated themselves as signifi-
cantly less healthy than depressed patients and
controls. In turn, the depressed group also rated
themselves as less physically healthy than
controls.
Illness beliefs
Both CFS groups showed a significantly stronger
somatic illness identity as they endorsed a higher
number of physical symptoms to their illness
than did depressed patients. There was no
differences between the two CFS groups on this
measure. Similarly, the two CFS groups made
significantly more physical attributions and
significantly fewer psychological attributions for
their illness than did depressed patients.
Cognitive distortions
To assess whether level and type of cognitive
distortion varied with group membership, the
two subscales of the CEQ-R were entered into
two separate ANOVA equations. There was a
highly significant difference for group on both
subscales. Post-hoc analyses revealed that the
depressed group scored significantly higher than
all the other three groups on the General CEQ-
R. There was no difference between the two CFS
groups and healthy controls on this subscale.
However, all three patient groups scored signifi-
cantly higher on the somatic CEQ-R when
compared with healthy controls.
Coping
As predicted, both CFS groups were more likely
to deal with their illness by limiting activity and
stress than were the depressed group. There was
no difference on this measure between the CFS
groups.
Stability of cognitions over 6 months
Identical analyses were conducted on the
measures included in the second questionnaire.
Table 4 shows that there was almost no change
in the pattern of results. The three groups were
still indistinguishable on measures of vitality
and sickness-related disability. Both the de-
pressed groups scored lower on psychological
well-being (MHI-5) than did the CFS group.
However, unlike at time one, the CFS-depressed
group did not score significantly higher than the
depressed group on this scale. Both of these
groups scored higher on this scale than at time
one, suggesting that their mood had improved
over the 6-month period.
The prototype of cognitive differences was
unchanged. The CFS groups rated themselves as
less healthy and experiencing more physical
symptoms as part of their illness. The depressed
group scored higher on the General CEQ-R but
not the Somatic CEQ-R. Interestingly, although
the groups showed improvements in their levels
of disability and symptom reports over the 6-
month period, within-group analyses showed
that there were no significant changes in scores
on the CEQ-R subscales in either of the groups.
For the CFS group the results of the paired
samples t tests on Somatic CEQ-R were tfl 0–83
(50) Pfl 0–41 and on the General CEQ-R, tfl
fi0–74 (50) Pfl 0–46. For the depressed group
the results on the Somatic CEQ-R were tfl
fi0–16 (16) Pfl 0–88 and on the General CEQ-
R, tfl 0–47 (16) Pfl 0–64.
Cognitive-behavioural variables and ongoing
disability and fatigue in CFS
Three separate stepwise regression equations
were used to investigate the relationships be-
tween the CFS-related cognitive-behavioural
factors measured at time one, and disability and
fatigue measured 6 months later in the CFS
group. The dependent variables included the
Vitality scale as a measure of fatigue and the two
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Table 4. Analysis of variance of the self-report measures at 6 months follow-up
CFS CFS-depressed Depressed
Mean (s.d.) Mean (s.d.) Mean (s.d.) df F
Vitality 30–14 (21–97) 30–36 (18–76) 41–18 (18–50) 2,65 1–82
MHI-5 69–62 (13–77) 56–57 (15–11) 52–00 (25–38) 2,65 6–85*
SIP dysfunction 37–03 (17–87) 37–50 (17–05) 26–93 (16–21) 2,65 2–27
SIP work 46–95 (26–18) 34–80 (28–32) 41–03 (25–71) 2,53 1–04
Self-rated health 3–59 (0–83) 3–71 (0–83) 2–76 (0–90) 2,65 6–67*
General CEQ-R 22–84 (11–53) 24–71 (9–29) 33–29 (11–11) 2,65 5–34*
Somatic CEQ-R 21–65 (9–10) 22–50 (4–60) 23–49 (9–66) 2,65 0–27
Somatic illness identity 17–03 (4–54) 17–00 (3–38) 9–50 (6–10) 2,65 17–64*
* P! 0–007.
 Significantly different from the depressed group.
 Significantly different from the CFS group.
SIP variables, general dysfunction and work
disability.
In each of the equations, age and length of
illness were entered as independent variables
together with physical attributions, somatic
illness identity, the Somatic CEQ-R, and limiting
coping. For vitality, both somatic illness identity
and age entered the equation and accounted for
a unique 21% of the variance, F (1,41)fl 12–52,
P!0–001). Somatic illness identity was the
strongest predictor (bflfi0–48, P! 0–001) fol-
lowed by age (bfl 0–31, P!0–05). Somatic illness
identity (bflfi0–61, P! 0–001) and the Somatic
CEQ-R (bfl 0–26, P!0–05) were the only sig-
nificant predictors of dysfunction. Together
these variables accounted for 38% of the
variance in dysfunction, F (1,41)fl 24–60,
P! 0–001. Somatic illness identity (bfl 0–56,
P! 0–001) was once again the first variable to
enter the equation for work dysfunction with
limiting coping (bfl 0–51, P! 0–001) also a
significant predictor. Taken together these two
variables accounted for a unique 24% of the
variance in work dysfunction, F (1,32)fl 10–32,
P!0–01.
DISCUSSION
The results generally supported the hypothesis
that depressed patients’ self-schema are domin-
ated by a negative view of the self, while CFS
patients are primarily concerned with their poor
health. Both depressed groups had lower self-
esteem than healthy controls and CFS non-
depressed patients, while both CFS groups rated
themselves as significantly less healthy than the
other two groups. The primary depressed
group’s ratings of health lay midway between
those of controls and the CFS groups.
The symptom profiles of each of the patient
groups to some extent reflected the differences in
these self-schemas. The groups were clearly
delineated on the affective dimension of psycho-
logical well-being with the primary depressed
patients being the most distressed and the
healthy controls the least distressed. CFS
patients fell in between these groups with the
CFS-depressed patients reporting more distress
than the non-depressed ones. The three patient
groups were indistinguishable on the somatic
dimension of distress, with all three groups
reporting substantially lower levels of vitality
than healthy controls.
With regard to illness beliefs, there were no
differences between the two CFS groups, but
substantial differences between CFS and de-
pression. In accordance with previous research,
CFS patients made significantly more physical
attributions but fewer psychological attributions
for their illness than did depressed patients
(Powell et al. 1990). Both CFS groups also
ascribed a significantly larger number of somatic
symptoms to their illness than did the depressed
group. While this difference may merely reflect
the physical status of the CFS patients there are
arguments against this possibility. Earlier work
has shown that CFS patients ascribe a larger
number of somatic symptoms of their illness
than do patients with other chronic medical
conditions (Weinman et al. 1996). In the current
study, out of a total of 20 symptoms, the CFS
patients on average reported experiencing 18 as
a result of their illness. While some of these
symptoms such as fatigue and muscle pain are
characteristic of CFS, others such as pins-and-
needles and sore eyes are symptoms commonly
experienced in the population as a whole. This
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suggests that CFS patients may misattribute
common symptoms to their illness.
CFS patients’ preoccupation with their
symptoms rather than with their sense of self is
also reflected in the CEQ-R data. CFS patients
only displayed distorted thinking in situations
where they might experience symptoms and not
in general interpersonal situations. Concurrent
depression did not appear to alter this pattern of
thinking. Only the depressed group could be
distinguished from the healthy controls on the
tendency to distort the meaning of interpersonal
situations. It is interesting that although the
depressed patients do not view their health as
negatively as the CFS group, and do not respond
to their illness by limiting stress and activity to
the same extent, they have a similar tendency to
report somatic errors in thinking. For this group,
somatic errors may be reflective of a generalized
tendency to see the world in a negative fashion.
The differences between CFS and depression
were maintained over the 6 month period. There
were no significant changes in the scores on
either the Somatic or General CEQ-R, sug-
gesting that these may be relatively stable
thought processes or ways of viewing the world.
It is also worth noting that CFS-depressed
patients showed greater overlap with CFS
patients than with primary depressed patients at
both time points.
In support of the cognitive behavioural
models, the CFS-related cognitive behavioural
factors predicted ongoing disability and fatigue
in this group, even when controlling for age and
length of illness. Somatic illness identity was the
most significant predictor of both ongoing
dysfunction and fatigue. Coping by limiting
stress and activity was associated with work-
related dysfunction, while somatic cognitive
errors were associated with disability in the
other domains. Interestingly, consistent with
previous work in this area (Moss-Morris et al.
1996; Heijmans & de Ridder, 1998), physical
attributions which are one of the key defining
features of the illness, failed to predict outcome
in this group. Changes in physical attributions
also fail to predict successful outcome in CFS
patients following cognitive behavioural therapy
(Deale et al. 1998). These results suggest that
therapy approaches which assist CFS patients to
reinterpret the meaning of their symptoms in
conjunction with exploring coping responses,
which encourage rather than limit activity, may
help to alleviate some of the negative disabling
effects of the illness. It may be particularly
important to explore alternative labels for
symptoms. For instance, some of the somatic
symptoms patients attribute to their CFS could
be re-labelled as signs of deconditioning, while
others such as headaches could be attributed to
stress. It appears to be less important to alter
patients’ beliefs that their illness is caused by
physical factors. This factor may in fact be
adaptive in that it may help to maintain a
healthy self-esteem.
Taken together, the results of this study are
consistent with a growing body of evidence that
argues against CFS being a version of de-
pression. It also provides some support for the
role cognitions and behaviour play in the
maintenance of CFS. However, a limitation of
the current study was the small sample sizes
and the convenience sampling method make it
difficult to generalize the results to all CFS and
depressed patients. It is also difficult to confirm
the directional links of these models from this
comparative study. It is possible that the
cognitive profile in CFS is a reflection of the fact
that these patients have a serious ongoing
physical illness. However, two findings argue
against this possibility. First, CFS patients
appear to have even more negative views of their
illness than do patients with other chronic
physical illnesses and these beliefs are associated
with ongoing disability and fatigue. Secondly,
although numerous physiological abnormalities
have been documented in CFS, these are seldom
associated with the magnitude of the symptoms
experienced by CFS patients (Wessely, 1996).
Prospective research in this area and studies that
compare CFS patients to patients with other
physical illnesses could help to address the nature
of CFS patients’ cognitions further.
This research was supported by the Health Research
Council of New Zealand.
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